Nose-to-brain delivery

Z Wang, G Xiong, WC Tsang, AG Schätzlein… - … of Pharmacology and …, 2019 - ASPET
The global prevalence of neurologic disorders is rising, and yet we are still unable to deliver
most drug molecules, in therapeutic quantities, to the brain. The blood brain barrier consists …

Facts and evidences on the lyophilization of polymeric nanoparticles for drug delivery

P Fonte, S Reis, B Sarmento - Journal of controlled release, 2016 - Elsevier
Lyophilization has been used to improve the long-term stability of polymeric nanoparticles
for drug delivery applications, avoiding their instability in suspension. However, this …

Absorption enhancers for nasal drug delivery

SS Davis, L Illum - Clinical pharmacokinetics, 2003 - Springer
This paper describes the basic concepts for the transmucosal delivery of drugs, and in
particular the use of the nasal route for delivery of challenging drugs such as polar low …

Emerging protein delivery methods

JL Cleland, A Daugherty, R Mrsny - Current opinion in biotechnology, 2001 - Elsevier
The efficient and safe delivery of therapeutic proteins is the key to commercial success and,
in some cases, the demonstration of efficacy in current and future biotechnology products …

In vivo animal models for drug delivery across the lung mucosal barrier

SA Cryan, N Sivadas, L Garcia-Contreras - Advanced drug delivery reviews, 2007 - Elsevier
Over recent years the research focus within the field of respiratory drug delivery has
broadened to include a wide range of potential applications for inhalation by delivering …

Preparation and characterization of biodegradable paclitaxel loaded alginate microparticles for pulmonary delivery

S Alipour, H Montaseri, M Tafaghodi - Colloids and Surfaces B …, 2010 - Elsevier
In primary or metastatic lung cancer, administration of chemotherapeutic agents via
inhalation could increase exposure of lung tumor to the drug, while minimizing systemic side …

Prospects of formulating proteins/peptides as aerosols for pulmonary drug delivery

SA Shoyele, A Slowey - International journal of pharmaceutics, 2006 - Elsevier
Formulation of proteins/peptides for therapeutic uses has often posed some challenges to
drug formulators. The main problem is the relatively weak forces involved in the native …

The effect of chitosan on transcellular and paracellular mechanisms in the intestinal epithelial barrier

R Rosenthal, D Günzel, C Finger, SM Krug, JF Richter… - Biomaterials, 2012 - Elsevier
Chitosan is employed as an absorption enhancer for drug delivery strategies. Aim of this
study was to investigate the rapid effects on barrier properties of the intestinal epithelial cell …

Study on the pulmonary delivery system of apigenin-loaded albumin nanocarriers with antioxidant activity

ZE Pápay, A Kósa, B Böddi, Z Merchant… - Journal of Aerosol …, 2017 - liebertpub.com
Background: Respiratory diseases are mainly derived from acute and chronic inflammation
of the alveoli and bronchi. The pathophysiological mechanisms of pulmonary inflammation …

Enhancement of bronchial octreotide absorption by chitosan and N-trimethyl chitosan shows linear in vitro/in vivo correlation

BI Florea, M Thanou, HE Junginger… - Journal of Controlled …, 2006 - Elsevier
Chitosan is a biocompatible polysaccharide of natural origin that can act as a permeation
enhancer. In this study, we used an integral in vitro/in vivo correlation approach to: a) …